| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PHAT | Common Stock | Sale | $50,689 | -4,325 | -4.2% | $11.72 | 99,447 | 15 Jul 2024 | Direct | F1, F2 |
| holding | PHAT | Common Stock | 1,911 | 15 Jul 2024 | By 401(k) |
| Id | Content |
|---|---|
| F1 | Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. |
| F2 | Includes 1,009 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024. |